sugi.bio

Sugi.bio is a pioneering brand dedicated to advancing biomedical research through innovative data tools and databases. Specializing in open research, Sugi.bio offers a variety of products designed to enhance discovery and analysis in the biomedical field. The Sugi Atlas serves as a comprehensive catalog with over 52,000 canonical reference pages linked to primary sources, focusing on human genes, drugs, and diseases. At the heart of their offerings lies the BioBTree, a unified knowledge graph integrating over 80 biomedical datasets that provides direct query access via a REST API for AI-assisted research.

Sugi.bio also features Sugi Predict, which identifies human protein targets from an extensive patent database, and Sugi Variant, a detailed reference for germline human variants that consolidates clinical classifications and frequency data. Additionally, the brand presents ReVUS, an open benchmark predicting the reclassification of variants of uncertain significance. To streamline operations, Enju serves as a collaborative workflow coordinator, ensuring that results are reproducible and auditable. Sugi.bio remains committed to providing free and open access to its resources for researchers worldwide.